Skip to main content
Clinical Trials/CTRI/2021/03/032083
CTRI/2021/03/032083Not yet recruitingPhase 2

A Clinical Study to Evaluate the Safety and Efficacy of Joshanda(Decoction) of Aftimoon(Cuscuta Reflexa Roxb) and Topical Application of Qust(Saussurea Lappa Clarke) with Honey in the Management of Kalaf(Melasma).

Central Council of Research in Unani Medicine New Delhi0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • The following patients will be included:
  • 1.Clinically diagnosed patients of Kalaf.
  • 2.Irrespective of all genders.
  • 3.patients between the age of 15 to 50 years.

Exclusion Criteria

  • The following patients will be excluded:
  • 1.Patients with history of Cardiovascular,Endocrine, Renal and Liver Diseases.
  • 2.Skin sensitivity by history and clinical examination.
  • 3.Pregnancy, Lactation and patients on oral contraceptives.
  • 4.Patients on Anticoagulants.

Investigators

Sponsor
Central Council of Research in Unani Medicine New Delhi

Similar Trials

Effect of Decoction of Cuscuta Reflexa and... | Clinical Trial